- Home
- OSUR vs FDMT Comparison
OSUR vs FDMT Comparison
Compare OSUR & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- FDMT
- Stock Information
- Founded
- OSUR 2000
- FDMT 2013
- Country
- OSUR United States
- FDMT United States
- Employees
- OSUR N/A
- FDMT N/A
- Industry
- OSUR Medical/Dental Instruments
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- OSUR Health Care
- FDMT Health Care
- Exchange
- OSUR Nasdaq
- FDMT Nasdaq
- Market Cap
- OSUR 223.0M
- FDMT N/A
- IPO Year
- OSUR 1986
- FDMT 2020
- Fundamental
- Price
- OSUR $2.60
- FDMT $3.24
- Analyst Decision
- OSUR Hold
- FDMT Buy
- Analyst Count
- OSUR 2
- FDMT 8
- Target Price
- OSUR $5.50
- FDMT $30.29
- AVG Volume (30 Days)
- OSUR 444.5K
- FDMT 505.1K
- Earning Date
- OSUR 05-07-2025
- FDMT 05-20-2025
- Dividend Yield
- OSUR N/A
- FDMT N/A
- EPS Growth
- OSUR N/A
- FDMT N/A
- EPS
- OSUR N/A
- FDMT N/A
- Revenue
- OSUR $161,626,000.00
- FDMT $37,000.00
- Revenue This Year
- OSUR N/A
- FDMT $13,270.27
- Revenue Next Year
- OSUR $7.55
- FDMT N/A
- P/E Ratio
- OSUR N/A
- FDMT N/A
- Revenue Growth
- OSUR N/A
- FDMT N/A
- 52 Week Low
- OSUR $2.69
- FDMT $2.24
- 52 Week High
- OSUR $5.59
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- OSUR 30.12
- FDMT 48.07
- Support Level
- OSUR $2.91
- FDMT $3.19
- Resistance Level
- OSUR $3.09
- FDMT $3.80
- Average True Range (ATR)
- OSUR 0.11
- FDMT 0.28
- MACD
- OSUR -0.02
- FDMT 0.03
- Stochastic Oscillator
- OSUR 26.47
- FDMT 33.33
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.